Find and Pitch Jounalists, Get Your Story Covered

Tags: Chemical biology Microbiome Careers Lab life Society

	Profile	Recent Articles on Subject
1	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	How the race for the next obesity drug is shaping up - 30 days ago The view from overseas on tumult in U.S. science - about 2 months ago The biotech news stories you need to read today - about 2 months ago Eli Lilly seeks to join lawsuit on compounded drugs - 3 months ago Merck is a new year outlier with its diabetes drug - 3 months ago The biotech news you missed this week - 9 months ago STAT+: More tumult at BIO amid the company’s fourth CEO in four years - 10 months ago FDA chastens pet companies over antibiotics - over 1 year ago These are the need-to-know biotech stories from this weekend - over 1 year ago
2	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	The most essential and memorable JPM moments, recapped - 3 months ago East Asians under-represented in biopharma leadership - 3 months ago A key decision on compounding is expected this week - 4 months ago
3	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	The most essential and memorable JPM moments, recapped - 3 months ago
4	Jason Mast STAT News Writing about science, medicine. ScienceMedicineBusiness	The most essential and memorable JPM moments, recapped - 3 months ago
5	Mike Hennessy Jr, President and CEO Pharmacy Times Pro middleweight boxer. UK/Ireland. BoxingSports	Key Insights From ASH and SABCS Showcase Advancements for the Field of Oncology Pharmacy - 3 months ago
6	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Merck is broadening its pipeline as Keytruda’s patent cliff looms - 3 months ago 2024 PharmaVoice 100s: Clinical Trial Pros - 5 months ago 3 FDA approval dates to watch in the year’s final push - 7 months ago Read to lead: 6 books pharma execs swear by - 8 months ago The hunt for the brain’s biomarkers - 10 months ago Execs from Bayer, Kite and Orca sound off on their launch strategies for cell and gene therapies - 11 months ago 4 offbeat biotechs making a splash in the life sciences - 11 months ago Black Diamond looks to outwit cancer mutations - about 1 year ago
7	<em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. scienceinnovation	Advances in Cancer Therapies and Diagnostics - 3 months ago From the Expert: Click Chemistry and Bioorthogonal Applications - about 1 year ago
8	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	4 companies to watch in the accelerating gene editing race - 3 months ago 3 closely watched drugs that failed in the clinic - 4 months ago 2024 PharmaVoice 100s: Trailblazers - 6 months ago Neuro drugs are still faltering, despite rising investment - 8 months ago Pharma’s R&D gamble: picking pipeline winners in a risky field - 10 months ago Where competition is heating up in pharma - 10 months ago The biggest questions hanging over pharma in 2024 - about 1 year ago PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials - about 1 year ago 10 of our most read articles in 2023 - over 1 year ago PharmaVoice 100s: Clinical trial gurus - over 1 year ago 3 recent FDA adcomm rejections — and why they matter - over 1 year ago
9	Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile educationpolitics	Among 2024’s modest M&A action, cancer, immunology and neuroscience deals trickle in - 5 months ago 2024 PharmaVoice 100s: Cell and Gene Therapy Pioneers - 5 months ago 2024 PharmaVoice 100s: Biotech Pathfinders - 5 months ago As new Alzheimer’s biomarkers come into play, here’s where the money is going - 6 months ago AlphaFold’s Nobel Prize is ‘the dawn of a new era’ in mapping drug development potential - 6 months ago Don’t call it a comeback: Biotech’s CNS resurgence forges Big Pharma connections - 9 months ago After 33 years, Geron’s first approval marks a turn in Nobel-winning science - 9 months ago Why AlphaFold 3 is stirring up so much buzz in pharma - 11 months ago Now a biopharma powerhouse, Vertex’s R&D bedrock could deliver tomorrow’s blockbusters - 11 months ago An ocean of answers in a single cell — how proteomics can lead to better drugs - about 1 year ago One biotech’s 3 gene therapy hurdles: delivery, delivery and delivery - about 1 year ago Real Chemistry’s CEO on biopharma’s outlook in 2024 - over 1 year ago A biotech tackles drug discovery with transcription factor know-how - over 1 year ago The thorniest questions facing pharma, according to a leading bioethicist - over 1 year ago
10	Meenakshi Prabhune, PhD The Scientist Editor in chief at The Scientist. Science journalismscicommtravelblogging	The Journey to a Nobel Prize: A Protein Design and Structure Research Timeline - 6 months ago

Journalists covering biochemistry, Brush-up Summaries, click chemistry, drug delivery, drug development, Nobel Prize